CAM
EBS icon

Capstone Asset Management’s Emergent Biosolutions EBS Stock Holding History

Capstone Asset Management’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$234K Sell
6,910
-760
-10% -$23.5K 0.01% 1423
2017
Q1 		$223K Sell
7,670
-1,060
-12% -$32.3K 0.01% 1478
2016
Q4 		$287K Sell
8,730
-7,280
-45% -$218K 0.01% 1343
2016
Q3 		$505K Buy
16,010
+30
+0.2% +$872 0.01% 959
2016
Q2 		$449K Buy
15,980
+2,420
+18% +$94.9K 0.01% 996
2016
Q1 		$493K Sell
13,560
-100
-0.7% -$3.53K 0.01% 929
2015
Q4 		$547K Buy
13,660
+3,960
+41% +$138K 0.02% 862
2015
Q3 		$276K Buy
9,700
+870
+10% +$28.7K 0.01% 1296
2015
Q2 		$291K Sell
8,830
-4,730
-35% -$147K 0.01% 1318
2015
Q1 		$390K Buy
13,560
+1,190
+10% +$34.1K 0.01% 1247
2014
Q4 		$337K Sell
12,370
-1,590
-11% -$37.9K 0.01% 1306
2014
Q3 		$297K Hold
13,960
– – 0.01% 1363
2014
Q2 		$314K Buy
13,960
+2,356
+20% +$54.9K 0.01% 1362
2014
Q1 		$293K Sell
11,604
-250
-2% -$6.31K 0.01% 1430
2013
Q4 		$273K Sell
11,854
-120
-1% -$2.5K 0.01% 1581
2013
Q3 		$228K Buy
11,974
+400
+3% +$7.14K 0.01% 1796
2013
Q2 		$167K Buy
+11,574
New +$168K ﹤0.01% 1827

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AAM
Aberdeen Asset Management Aberdeen, United Kingdom $30B AUM 22.46% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Capstone Asset Management's EBS Position: Q2 2017 in Review

Capstone Asset Management reduced its Emergent Biosolutions (EBS) stake by 9.9% in Q2 2017, selling an estimated $23.5K and leaving 6,910 shares worth $234K. The position accounts for 0.01% of the portfolio, ranked #1423.

Capstone Asset Management first reported a position in EBS in Q2 2013 and has held it in 17 quarters since. The position peaked at $547K in Q4 2015. 181 funds tracked by Wall St. Rank hold EBS as of Q2 2017.

  • Capstone Asset Management held 6,910 shares of Emergent Biosolutions worth $234K as of Q2 2017.
  • Capstone Asset Management sold 760 Emergent Biosolutions shares in Q2 2017, an estimated $23.5K.
  • Emergent Biosolutions made up 0.01% of Capstone Asset Management's portfolio in Q2 2017, its #1423 holding.
  • Capstone Asset Management first reported a position in Emergent Biosolutions in Q2 2013 and has held it in 17 quarters since.
  • Capstone Asset Management's Emergent Biosolutions position peaked at $547K in Q4 2015.
  • 181 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2017.

Based on Capstone Asset Management's 13F filing for Q2 2017, filed 10 Jul 2017.